US OTC Makers Cite Progress With FDA

The theme of the US Nonprescription Drug Manufacturers Association'srecent manufacturing controls seminar was stated by its chairman succinctly at the outset: "Lots of good things are going on." Donald Cadge, director, contract operations and new business at Johnson & Johnson's McNeil Consumer Products unit, and chairman of the NPMA manufacturing controls committee, cited four positive trends:

- the Food and Drug Administration's decision to re-propose established rules on label printing and layout controls until completely new rules are instituted. The NDMA considers this "good, because it means that many rules currently in force won't become permanent," he said;

- the Product Quality Research Initiative, which the NDMA sees as acreative and forward-scientific thinking;"